News by Subject Medicine & Health

Biological samples can be highly susceptible to changes over time, which often occur when they are removed from deep refrigeration. Degraded samples can produce spurious results in research. To address these concerns, Borges and his colleagues have designed a highly sensitive test that can be used to establish the integrity of blood plasma and serum, the most common biosamples used in medical research.

In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalised treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up to one in every three operations could be avoided.

Research conducted by Suresh Alahari, PhD, Professor of Biochemistry and Genetics at LSU Health New Orleans School of Medicine, has found that metformin, a commonly prescribed drug for Type 2 Diabetes, may be effective in treating cancers that lack a protein called Nischarin.

An analysis of nearly 1.9 million patients diagnosed with breast cancer suggests overall survival is lower among men than women and that undertreatments and clinical characteristics account for much of the difference. The study included National Cancer Database data for 16,025 male and 1.8 million female patients diagnosed with breast cancer between 2004-2014. Men had higher mortality across all breast cancer stages.

Men at high risk of developing breast cancer may benefit from mammography, or breast X-ray, screening for the disease, a new study shows.

Results from the Quality of Life substudy of the NRG Oncology clinical trial NSABP B-39/RTOG 0413 indicate that women rated post-lumpectomy partial breast irradiation (PBI) as equivalent to whole breast irradiation (WBI) in terms of cosmetic outcomes and satisfaction from baseline to three years following radiotherapy treatment.

In a paper published today in the Journal of Medical Screening, researchers from King's College London and Queen Mary University of London have found that despite free cancer screening programs, only 35% take part in all offered programs.